Correction to: Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting

Shranjeno v:
Bibliografske podrobnosti
izdano v:Diabetes Ther
Main Authors: Gæde, Peter, Johansen, Pierre, Tikkanen, Christian Klyver, Pollock, Richard Fulton, Hunt, Barnaby, Malkin, Samuel Joseph Paul
Format: Artigo
Jezik:Inglês
Izdano: Springer Healthcare 2019
Teme:
Correction
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6612334/
https://ncbi.nlm.nih.gov/pubmed/31152431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-019-0638-y
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki